Isatin → ethyl (4-bromo-2,3-dioxo-2,3-dihydro-1H-indol-1-yl)acetate
Reaction equation
N1C2C(=CC=CC=2)C(=O)C1=O.[Br:12][C:13]1[CH:21]=[CH:20][CH:19]=[C:18]2[C:14]=1[C:15](=[O:23])[C:16](=[O:22])[NH:17]2.BrCCC1CC1.Br[CH2:31][C:32]([O:34][CH2:35][CH3:36])=[O:33]>>[CH2:35]([O:34][C:32](=[O:33])[CH2:31][N:17]1[C:18]2[C:14](=[C:13]([Br:12])[CH:21]=[CH:20][CH:19]=2)[C:15](=[O:23])[C:16]1=[O:22])[CH3:36]Participants
5
Procedure
Following the procedure as described in PREPARATION 2A, and making non-critical variations to replace isatin with 4-bromoisatin and (2-bromoethyl)cyclopropane with ethyl bromoacetate, the title compound was obtained as a yellow solid (68%): 1H NMR (300 MHz, CDCl3) δ 7.39 (t, 1H), 7.27(dd, 1H), 6.71 (dd, 1H), 4.47 (s, 2H), 4.23 (q, 2H), 1.27 (t, 3H); MS (ES+) m/z 312 (M+1), 314 (M+1), 334 (M+23), 336 (M+23).
Sources & evidence
- ORD record
- ord-1e9a9980b76a417985a4dd654754404d
- Source dataset
- uspto-grants-2010_04
- Patent number
- US07700641B2
Reaction notes
Loading…